Clinical trial
A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers.
NCT01765868 is registered in ClinicalTrials.gov with Portola Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers.
- Lead sponsor
- Portola Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- October 31, 2007
- Enrollment
- 8 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subjects